Arkolith/Insider Trading/IDXG/Form 4

1315 Capital II, L.P.

10% OwnerINTERPACE BIOSCIENCES, INC. (IDXG) · full profile →Form 4 · filed Feb 17, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 20, 2026Conversion(C)9.4M$2.02$19.0M9.4M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 20, 2026Conversion(C)19K—$00

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-26-007093) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML